Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  Pandey, Sanjay ^a   Rathore, Chaturbhuj ^b   Michael, Benedict D ^c,d  

^a G B PANT HOSPITAL   (India)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; VALPROIC ACID;

DATA BASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; EPILEPTIC STATE; HUMAN; MORBIDITY; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SECONDARY PREVENTION; SEIZURE; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VIRUS ENCEPHALITIS; COMPLICATION; SEIZURES;

ANTICONVULSANTS; ENCEPHALITIS, VIRAL; HUMANS; PRIMARY PREVENTION; SECONDARY PREVENTION; SEIZURES;

EID: 84921991226     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010247.pub2     Document Type: Review

References (25)

1. Chen WB, Gao R, Su YY, Zhao JW, Zhang YZ, Wang L, et al.Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. European Journal of Neurology 2011;18(12):1391-6.
2. Huang Y, Yang L, Wang S, Wang G. Alterative application of five anticonvulsants according to the half life for the treatment of status epilepticus in children with severe viral encephalitis. Neural Regeneration Research 2007;2(9):561-4.
3. Zhang SY, Huang YZ, Yang LB, Zhang SS, Wang ZG, Jiang Y. Evaluation of therapeutic effect of reformed subhibernation therapy for status epilepticus in children with severe viral encephalitis. Journal of Jilin University Medicine 2009;35(5):928-31.
4. Annegers JF, Grabow JD, Groover RV, Laws ER, Elveback LR, Kurland LT. Seizures after head trauma: a population study. Neurology 1980;30:683-9.
5. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988;38(9):1407-10.
6. Chen YJ, Fang PC, Chow JC. Clinical characteristics and prognostic factors of postencephalitic epilepsy in children. Journal of Child Neurology 2006;21(12):1047-51.
7. Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D, et al.Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet 2000;355(9205):701-6.
8. Granerod J, Crowcroft NS. The epidemiology of acute encephalitis. Neuropsychological Rehabilitation 2007;17(4-5):406-28.
9. Health Protection Agency. Investigation of Viral Encephalitis and Meningitis. UK Standards for Microbiology Investigations. G 4 Issue 2.2. 2011. Available from http://www.hpa.org.uk/SMI/pdf.
10. Hsieh WB, Chiu NC, Hu KC, Ho CS, Huang FY. Outcome of herpes simplex encephalitis in children. Journal of Microbiology, Immunology and Infection 2007;40:34-8.
11. Johnson RT. Acute encephalitis. Clinical Infectious Diseases 1996;23:219-24.
12. Kalita J, Misra UK, Pandey S, Dhole TN. A comparison of clinical and radiological findings in adults and children with Japanese encephalitis. Archives of Neurology 2003;60:1760-4.
13. Kalita J, Nair PP, Misra UK. Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs. Journal of Neurovirology 2008;14(5):412-7.
14. Koskiniemi M, Korppi M, Mustonen K, Rantala H, Muttilainen M, Herrgård E, et al.Epidemiology of encephalitis in children. A prospective multicentre study. European Journal of Pediatrics 1997;156(7):541-5.
15. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://www.cochrane-handbook.org/.
16. Marks DA, Kim J, Spencer DD, Spencer SS. Characteristics of intractable seizures following meningitis and encephalitis. Neurology 1992;42:1513-8.
17. Michael BD, Solomon T. Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms. Epilepsia 2012;53 Suppl(4):63-71.
18. Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia 2008;49 Suppl 6:13-8.
19. Solomon T, Dung NM, Kneen R, Thao le TT, Gainsborough M, Nisalak A, et al.Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002;125(Pt 5):1084-93.
20. Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ, et al.National Encephalitis Guidelines Development and Stakeholder Groups. Management of suspected viral encephalitis in adults: Association of British Neurologists and British Infection Association National Guideline. Journal of Infection 2012;64(4):347-73.
21. Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al.Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. European Journal of Neurology 2010;17:999-e57.
22. Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, Chew NK, et al.Relapsed and late-onset Nipah encephalitis. Annals of Neurology 2002;51:703-8.
23. Thakur KT, Motta M, Asemota AO, Kirsch HL, Benavides DR, Schneider EB, et al.Predictors of outcome in acute encephalitis. Neurology 2013;81(9):793-800.
24. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al.The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2008;47:303-27.
25. World Health Organization. Recommended standards for surveillance of selected vaccine-preventable diseases. Available from: http://www.who.int/vaccines-documents/DocsPDF06/843.pdf. Geneva: World Health Organization, 2006.